Development of Unprecedented Aluminosilicate Adjuvants (2021-2023)
Abstract
High-performance adjuvants are essential components of vaccine technology. Aluminium-based adjuvants are widely used, but provide weak cellular immunity and possible risk of neurotoxicity. Combining state-of-the-art nanotechnology and classic coordination chemistry, this project aims to apply a new design principle to create novel mesoporous aluminosilicate nanoparticles with alkalinity, for use as nanoadjuvants. This project expects to advance knowledge of how immune systems respond to changes in chemistry and nanostructure of aluminosilicate materials and enable the design of nanoadjuvants with enhanced cellular immunity and reduced toxicity. Outcomes include a new family of functional materials with unprecedented adjuvant performance.
